Navigation Links
InVitria to Present at BIO 2009 International Convention in Atlanta
Date:5/19/2009

InVitria to profile "New Strategies for Optimizing CHO Performance" inside the BIO Process Product Zone on May 20, 2009 in Atlanta, GA.

Fort Collins, CO (PRWEB) May 19, 2009 -- Amidst the sea of people, products and presentations at the BIO 2009 International Convention will be InVitria, a cell culture media supplement company that provides performance enhancing components for CHO and hybridoma cell culture media. InVitria's cell culture media supplement products will be part of the BIO Process Product Zone exhibition in Booth #5120 within the Georgia World Congress Center from May 18-21.

InVitria's products will also be showcased in the BioProcess Theater, a site located on the exhibition floor and sponsored by BioProcess International to facilitate the sharing of advances and discoveries in the biopharmaceutical sector. InVitria's Director of Cell Culture, Dr. Steve Pettit, will present the performance enhancing features of ZAP-CHO, a new media component for Chinese hamster ovary (CHO) cell culture. Dr. Pettit will present the advantages of this new cell culture supplement at 3:30 pm on Wednesday, May 20 inside the BioProcess Theater.

ZAP-CHO, a new product from InVitria, enhances performance of mammalian cell culture including improved cell growth and antibody production. It achieves these performance advantages in chemically defined media that are completely free of animal components. Previously, the performance seen with ZAP-CHO was only possible by utilizing animal components such as FBS (fetal bovine serum), BSA (bovine serum albumin) or plasma-derived HSA (human serum albumin) in cell culture media.

"Our team of scientists has developed supplements that not only meet the regulatory requirements of researchers using hybridoma and CHO cell culture, but it exceeds their performance expectations as well," said Dr. Pettit. "InVitria products have been utilized by customers to successfully achieve greater cell productivity and growth; faster cell doublings; and improved consistency."

About InVitria:
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's performance enhancing reagents, contact us at info @ InVitria.com or call 1-800-916-8311.

###

Read the full story at http://www.prweb.com/releases/BIO2009/ZAP-CHO/prweb2435574.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria Reveals Technology to Optimize Hybridoma Production Performance
2. InVitria Headlines Sponsorship of WilBio's Waterside Conference
3. InVitria Announces Launch of Recombinant Albumin for Diagnostics
4. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
5. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
6. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
7. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
8. InVitria to Present at WilBio's International Cell Engineering Meeting
9. Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting
10. Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting
11. Covance to Present at the Deutsche Bank 34th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... Berkeley, and other leading institutions in announcing the launch of the Leadership ... the way animals are raised for food. , Founding members of the Leadership ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , Sept. ... Penn. , and OptiMed Specialty Pharmacy of ... partnership to offer a strategic hub service that expedites ... highly sought-after personal spirometer, Spiro PD 2.0, and wellness ... A spirometer is a medical device used to measure ...
Breaking Medicine Technology: